The 7 linked references in paper E. Anaev Kh., K. Fedorchenko Yu., M. Kushaeva E., A. Ryabokon' M., A. Kononikhin S., V. Barmin V., O. Pikin V., I. Popov A., E. Nikolaev N., S. Varfolomeev D., A. Chuchalin G., Э. Анаев Х., К. Федорченко Ю., М. Кушаева Э., А. Рябоконь М., А. Кононихин С., В. Бармин В., О. Пикин В., И. Попов А., Е. Николаев Н., С. Варфоломеев Д., А. Чучалин Г. (2017) “Диагностика заболеваний легких на основе протеомного анализа конденсата выдыхаемого воздуха // Diagnosis of respiratory diseases using the proteomic analysis of exhaled breath condensate” / spz:neicon:pulmonology:y:2017:i:2:p:187-197

  1. Konstantinidi E.M., Lappas A.S., Tzortzi A.S., Behrakis P.K. Exhaled Breath Condensate: Technical and Diagnostic Aspects.Scientific World Journal. 2015; 2015: 435160. DOI: 10.1155/2015/435160.
  2. Borrill Z.L., Roy K., Singh D. Exhaled breath condensate biomarkers in COPD. Eur. Respir. J. 2008; 32 (2): 472–486. DOI: 10.1183/09031936.00116107.
  3. Bloemen K., Hooyberghs J., Desager K. et al. Non-invasive biomarker sampling and analysis of the exhaled breath proteome. Proteomics Clin. Appl. 2009; 3 (4): 498–504. DOI: 10.1002/prca.200800095. Оригинальные исследования
  4. Lin J.L., Bonnichsen M.H., Nogeh E.U. et al. Proteomics in detection and monitoring of asthma and smoking-related lung diseases. Exp. Rev. Proteomics. 2010; 7 (3): 361–372. DOI: 10.1586/epr.10.9.
  5. Lim M.Y., Thomas P.S. Biomarkers in exhaled breath condensate and serum of chronic obstructive pulmonary disease and non-small-cell lung cancer. Int. J. Chronic Dis.2013; 2013: 578613. DOI: 10.1155/2013/578613.
  6. Nobakht M. Gh B.F., Aliannejad R., Rezaei-Tavirani M. et al. The metabolomics of airway diseases, including COPD, asthma and cystic fibrosis. Biomarkers. 2015; 20 (1): 5–16. DOI: 10.3109/1354750X.2014.983167.
  7. Terracciano R., Pelaia G., PreianòM., Savino R. Asthma and COPD proteomics: current approaches and future directions. Proteomics Clin. Appl.2015; 9 (1–2): 203–220. DOI: 10.1002/prca.201400099.